Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
Open | $0.72 |
Close | $0.77 |
Volume / Avg. | 3.27M / 723.03K |
Day Range | 0.72 - 0.78 |
52 Wk Range | 0.68 - 4.14 |
Market Cap | $51.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 18 |
Short Interest | 4.9% |
Days to Cover | 23.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS), CollPlant Biotechnologies (NASDAQ:CLGN) and BioLine Rx (NASDAQ:BLRX).
There is no analysis for Ovid Therapeutics.
Ovid Therapeutics has a consensus price target of $4.74.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $0.732 last updated June 28, 2024 at 6:08 PM EDT.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.